Extracellular matrix (ECM) degradation and related proteases, including cathepsin S, matrix metalloproteinase-2 (MMP2), and MMP9, are significantly reduced in the Smarcd1SMKO AAA specimen. Here, MMP2 is linked to triple-A syndrome.